论文部分内容阅读
OBJECTIVE: Cisplatin is the first-line chemotherapy for the treatment of non-small cell lung cancer (NSCLC).However, its resistance has been a major obstacle in the management of NSCLC.Aldehyde dehydrogenaselA1 (ALDH1A1) over-expression has been observed in a variety of cancers, including lung cancer.The purpose of this study was to investigate the effect of ALDH1A1 expression on cisplatin resistance and to explore potential mechanism.